Share Price:
Print
Alert

Medicine safety

medicine-safety-1280x259

Part of our responsibility as a global pharmaceutical company is to ensure the safety of the patients who use our products. At Hikma, we are committed to medicine safety in all cases where the medicine is prescribed to patients.

Through our robust commitment to pharmacovigilance, we ensure we remain focused on patients' safety. Our Medical Affairs department manages a pharmacovigilance system for the collection, collation, and evaluation of adverse drug reactions and the implementation of effective corrective and preventive actions.

For further information or to report adverse reactions please contact pharmacovigilance@hikma.com.

United States Consumer Product Safety Improvement Act of 2008

Set out below are the Certificate of Compliance and related Product List by NDC in relation to the compliance by West-Ward Pharmaceutical Corp., with the United States Consumer Product Safety Improvement Act of 2008.

Certificate of Compliance
Product listing

For additional information, please contact one of the following:

Ms. Elizabeth Marro
Vice President, Quality Unit
435 Industrial Way West
Eatontown, NJ 07724
Telephone: 732-542-1191 ext. 2868
Email: emarro@west-ward.net

Mr Aric Blount
Manager, Quality Assurance
465 Industrial Way West
Eatontown, NJ 07724
Telephone: 732-542-1191 ext. 2853
Email: ablount@west-ward.net

Mr Don Ferri
Group Leader, Quality Compliance
465 Industrial Way West
Eatontown, NJ 07724
Telephone: 732-542-1191 ext. 2824
Email: dferri@west-ward.net

YOU MAY ALSO BE INTERESTED IN...

Corporate governance

Our Board of Directors is committed to the standards of corporate governance.

Our Code of Conduct

We are committed to maintaining high standards of ethical conduct.